Maxim Biotechnologies Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $369M

Maxim Biotechnologies General Information

Description

Developer of tumor pathology immunohistochemical diagnostic reagents and testing instruments. The company's business covers tumor pathological diagnosis, immunocytochemical diagnosis, molecular pathological diagnosis, and precision medical diagnosis, enabling medical institutes to improve medical detection accuracy and reduce costs.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Building 12, Haixi Innovation Park
  • High-tech Zone, Wulongjiang Middle Avenue
  • Fuzhou, Fujian
  • China
+86 800
Primary Industry
Diagnostic Equipment
Other Industries
Medical Supplies
Biotechnology
Vertical(s)
Corporate Office
  • Building 12, Haixi Innovation Park
  • High-tech Zone, Wulongjiang Middle Avenue
  • Fuzhou, Fujian
  • China
+86 800

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Maxim Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 15-Jun-2020 $369M Completed Generating Revenue
1. Later Stage VC 01-Jan-2017 Completed Generating Revenue
To view Maxim Biotechnologies’s complete valuation and funding history, request access »

Maxim Biotechnologies Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
CDH Investments PE/Buyout Minority
GAC Capital Corporate Venture Capital Minority
GL Capital Group Growth/Expansion Minority
Taikang Insurance Group PE-Backed Company Minority
To view Maxim Biotechnologies’s complete investors history, request access »

Maxim Biotechnologies FAQs

  • When was Maxim Biotechnologies founded?

    Maxim Biotechnologies was founded in 1993.

  • Where is Maxim Biotechnologies headquartered?

    Maxim Biotechnologies is headquartered in Fuzhou, China.

  • What industry is Maxim Biotechnologies in?

    Maxim Biotechnologies’s primary industry is Diagnostic Equipment.

  • Is Maxim Biotechnologies a private or public company?

    Maxim Biotechnologies is a Private company.

  • What is the current valuation of Maxim Biotechnologies?

    The current valuation of Maxim Biotechnologies is .

  • What is Maxim Biotechnologies’s current revenue?

    The current revenue for Maxim Biotechnologies is .

  • Who are Maxim Biotechnologies’s investors?

    CDH Investments, GAC Capital, GL Capital Group, and Taikang Insurance Group have invested in Maxim Biotechnologies.

  • When was Maxim Biotechnologies acquired?

    Maxim Biotechnologies was acquired on 15-Jun-2020.

  • Who acquired Maxim Biotechnologies?

    Maxim Biotechnologies was acquired by Beijing Strong Biotechnologies and China National Pharmaceutical Investment.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process